Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 3 (2006), Issue 12 (December)

1. Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells.
   FEBS Lett, 580(28): 6565-9. [Abstract] [Full-text]
2. A novel system to study adenovirus tropism to normal and malignant colon tissues.
   Virology, 357(1): 91-101. [Abstract] [Full-text]
3. Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes.
   Int J Cancer, 120(3): 524-32. [Abstract] [Full-text]
4. Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids.
   Int J Cancer, 120(3): 632-7. [Abstract] [Full-text]
5. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
   Int J Cancer, 120(3): 585-93. [Abstract] [Full-text]
6. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
   Int J Cancer, 120(3): 656-63. [Abstract] [Full-text]
7. Progression of tumors arising from large ACF is associated with the MUC5AC expression during rat colon MNNG carcinogenis.
   Int J Cancer, 120(3): 477-83. [Abstract] [Full-text]
8. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
   J Surg Res, 137(1): 75-82. [Abstract] [Full-text]
9. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy.
   N Engl J Med, 355(24): 2533-41. [Abstract] [Full-text]
10. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
    Carcinogenesis, 28(1): 21-7. [Abstract] [Full-text]
11. Evaluation of laser microdissection as a tool in cancer glycomic studies.
    Biochem Biophys Res Commun, 352(3): 579-86. [Abstract] [Full-text]
12. Characterization of a novel oncogenic K-ras mutation in colon cancer.
    Biochem Biophys Res Commun, 352(3): 728-32. [Abstract] [Full-text]
13. Prognostic value of humbug gene overexpression in stage II colon cancer.
    Hum Pathol, 38(1): 17-25. [Abstract] [Full-text]
14. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.
    JAMA, 296(23): 2815-22. [Abstract] [Full-text]
15. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
    Cancer Res, 66(24): 11700-8. [Abstract] [Full-text]
16. Effect of directed training on reader performance for CT colonography: multicenter study.
    Radiology, 242(1): 152-61. [Abstract] [Full-text]
17. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway.
    Cancer Lett, 247(1): 115-21. [Abstract] [Full-text]
18. CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients.
    Eur J Immunol, 37(1): 282-91. [Abstract] [Full-text]
19. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
    J Clin Oncol, 25(1): 102-9. [Abstract] [Full-text]
20. Voltage-gated K+ channels support proliferation of colonic carcinoma cells.
    FASEB J, 21(1): 35-44. [Abstract] [Full-text]
21. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
    Cancer Immunol Immunother, 56(3): 359-70. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.